EPISODE · Aug 14, 2026 · 4 MIN
Chanel's Steady Half, Spicules Go Direct
from Beauty in Five
Chanel reports first-half growth in beauty division. Global Cosmetics News reports Chanel's fragrance and beauty arm grew in the first half of 2026, a read on whether prestige beauty is holding up as wider luxury softens. (Global Cosmetics News) Dermata launches Tome, a weekly spicule skincare treatment. WWD Beauty reports ingredient developer Dermata is launching its own consumer brand, testing whether a $45 once-weekly at-home treatment can sit alongside in-clinic procedures. (WWD Beauty) KT and Amorepacific deploy AI assistant for product research. The partners say their generative-AI tool, Lemon, cuts research and regulatory review time in product development, time savings that are company-stated, not independently verified. (Global Cosmetics News) Also moving today: Have you heard of biotech beauty? We took a closer look (NewsChannel 3-12, CNN International) P&G Appoints Shailesh Jejurikar as Chairman Following Leadership Transition (Global Cosmetics News) Get Beauty in Five in your inbox every weekday: https://beautyinfive.com
Embed this episode
What this episode covers
Global Cosmetics News reports Chanel's fragrance and beauty division grew in the first half against what it calls a challenging luxury market, though the summary carries no figure or comparison base. WWD Beauty reports ingredient developer Dermata is going direct to consumers with Tome, a once-weekly spicule treatment priced at forty-five dollars, and Global Cosmetics News reports Amorepacific has put a generative AI research assistant called Lemon into production with Korean telecom KT to cut research and regulatory review time. Also moving: CNN examines fermentation-derived actives in biotech beauty, and Procter and Gamble names chief executive Shailesh Jejurikar chairman of the board following Jon Moeller's retirement.
Ready to play
Chanel's Steady Half, Spicules Go Direct
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.